Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study
2007-01-01 Fagotti, A; Ferrandina, G; Paris, I; Mari, A; Legge, F; Fanfani, F; Facchini, G; Scambia, G
Magnetic resonance imaging of pelvic endometriosis. Effect of reader's experience on accuracy and interobserver variability
2009-01-01 Restaino, G; Missere, M; Maselli, G; Mattioni, O; Calandriella, L; Carone, V; Legge, F; Ferandina, G; Sallustio, G
Endometriosis and Cancer
2009-01-01 Legge, F; Paglia, A; D’Asta, M; Carone, V; Scambia, G; Ferrandina, G
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer
2006-01-01 Ferrandina, G; Ludovisi, M; D’Agostino, G; Naldini, A; Lorusso, D; Testa, Ac; Legge, F; Salutari, V; Scambia, G
Gene therapy in gyncological cancer
2001-01-01 Scambia, G; Ferrandina, G; Legge, F; Fagotti, A; Fanfani, F; Mancuso, S
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer
2003-01-01 Ferrandina, G; Salutari, V; Legge, F; Ranelletti, Fo; Distefano, Mg; Gessi, M; Zannoni, Gf; Martinelli, E; Gallotta, V; Scambia, G
New drugs in ovarian cancer
2005-01-01 Legge, F; Ferrandina, G; Salutari, V; Scambia, G
Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients
2005-01-01 Legge, F; Ranelletti, Fo; Zannoni, Gf; Martinelli, E; Gessi, M; Salutari, V; Gallotta, V; Lorusso, D; Scambia, G; Ferrandina, G
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study
2003-01-01 Ferrandina, G; Ranelletti, Fo; Legge, F; Lauriola, L; Salutari, V; Gessi, M; Testa, Ac; Werner, U; Navarra, P; Tringali, G; Battaglia, A; Pozzo, C; Scambia, G
Is there a prognostic role for the pattern of recurrence in platinum-sensitive relapsing ovarian cancer patients?
2012-01-01 Legge, F; Petrillo, M; Pedone, L; Lucidi, A; Malaggese, M; Iannone, V; Borriello, M; Carone, V; Scambia, G; Ferrandina, G
Expression of surviving in locally advanced cervical cancer (LACC) patients administered chemoradiation (CT/RT) followed by radical surgery (RS): prediction of response and clinical outcome
2012-01-01 Iannone, V; Paglia, A; Martinelli, E; Fuoco, G; Legge, F; Borriello, M; Pedone, L; Zannoni, Gf; Carone, V; Ferrandina, G
Postoperative concomitant boost radiotherapy in high risk endometrial cancer
2012-01-01 Macchia, G; Morganti, Ag; Deodato, F; Cilla, S; Corrado, G; Legge, F; Malaggese, M; Massacesi, M; Scambia, G; Ferrandina, G
Indicatori molecolari prognostici e predittivi di risposta nel carcinoma ovarico
2000-01-01 Scambia, G; Fagotti, A; Legge, F; Ferrandina, G; Fanfani, F; Mancuso, S
Large-field pre-operative chemoradiation in locally advanced carcinoma of the cervix: preliminary results of a phase I study (LARA-CC-1)
2008-01-01 Macchia, G; Morganti, Ag; Legge, F; Deodato, F; Digesù, C; Ferro, M; Caravatta, L; Ruggieri, V; Cocciolo, A; Travaglini, C; Piscopo, A; Ferrandina, G; Scambia, G; Valentini, V; Cellini, N
Il carcinoma ovarico familiare
2000-01-01 Greggi, S; Legge, F; Laurelli, G; Paparatti, M
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) in patients with advanced ovarian cancer (AOC): final analysis of the MITO-2 randomized multicenter trial
2010-01-01 Pignata, S; Scambia, G; Savarese, A; Sorio, R; Breda, E; Legge, F; Gebbia, V; Musso, P; Gallo, C; Perrone, F on behalf of MITO group
Phase II study on Pemetrexed in advanced and/or recurrent cervical cancer patients: a MITO study
2008-01-01 Ferrandina, G; Lorusso, D; Ludovisi, M; Pignata, S; Sorio, R; Mangili, G; Breda, E; Legge, F; Pisconti, S; Scambia, G
Intensified pre-operative chemoradiation in locally advanced carcinoma of the uterine cervix: final resultsof a phase I-II study (ESTER-1)
2008-01-01 Macchia, G; Morganti, Ag; Legge, F; Deodato, F; Digesù, C; Ferro, M; Caravatta, L; Tambaro, R; Ferrandina, G; Sallustio, G; Smaniotto, D; Scambia, G; Valentini, V; Cellini, N
Verso la classificazione molecolare dei tumori: possibili implicazioni prognostiche e terapeutiche
2003-01-01 Legge, F; Ferrandina, G; Gallotta, V; Scambia, G
COX-2 inhibition in gynaecological cancers
2005-01-01 Legge, F; Ferrandina, G; Scambia, G. COX-2 inhibition in gynaecological cancers.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study | 1-gen-2007 | Fagotti, A; Ferrandina, G; Paris, I; Mari, A; Legge, F; Fanfani, F; Facchini, G; Scambia, G | |
| Magnetic resonance imaging of pelvic endometriosis. Effect of reader's experience on accuracy and interobserver variability | 1-gen-2009 | Restaino, G; Missere, M; Maselli, G; Mattioni, O; Calandriella, L; Carone, V; Legge, F; Ferandina, G; Sallustio, G | |
| Endometriosis and Cancer | 1-gen-2009 | Legge, F; Paglia, A; D’Asta, M; Carone, V; Scambia, G; Ferrandina, G | |
| Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer | 1-gen-2006 | Ferrandina, G; Ludovisi, M; D’Agostino, G; Naldini, A; Lorusso, D; Testa, Ac; Legge, F; Salutari, V; Scambia, G | |
| Gene therapy in gyncological cancer | 1-gen-2001 | Scambia, G; Ferrandina, G; Legge, F; Fagotti, A; Fanfani, F; Mancuso, S | |
| Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer | 1-gen-2003 | Ferrandina, G; Salutari, V; Legge, F; Ranelletti, Fo; Distefano, Mg; Gessi, M; Zannoni, Gf; Martinelli, E; Gallotta, V; Scambia, G | |
| New drugs in ovarian cancer | 1-gen-2005 | Legge, F; Ferrandina, G; Salutari, V; Scambia, G | |
| Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients | 1-gen-2005 | Legge, F; Ranelletti, Fo; Zannoni, Gf; Martinelli, E; Gessi, M; Salutari, V; Gallotta, V; Lorusso, D; Scambia, G; Ferrandina, G | |
| Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study | 1-gen-2003 | Ferrandina, G; Ranelletti, Fo; Legge, F; Lauriola, L; Salutari, V; Gessi, M; Testa, Ac; Werner, U; Navarra, P; Tringali, G; Battaglia, A; Pozzo, C; Scambia, G | |
| Is there a prognostic role for the pattern of recurrence in platinum-sensitive relapsing ovarian cancer patients? | 1-gen-2012 | Legge, F; Petrillo, M; Pedone, L; Lucidi, A; Malaggese, M; Iannone, V; Borriello, M; Carone, V; Scambia, G; Ferrandina, G | |
| Expression of surviving in locally advanced cervical cancer (LACC) patients administered chemoradiation (CT/RT) followed by radical surgery (RS): prediction of response and clinical outcome | 1-gen-2012 | Iannone, V; Paglia, A; Martinelli, E; Fuoco, G; Legge, F; Borriello, M; Pedone, L; Zannoni, Gf; Carone, V; Ferrandina, G | |
| Postoperative concomitant boost radiotherapy in high risk endometrial cancer | 1-gen-2012 | Macchia, G; Morganti, Ag; Deodato, F; Cilla, S; Corrado, G; Legge, F; Malaggese, M; Massacesi, M; Scambia, G; Ferrandina, G | |
| Indicatori molecolari prognostici e predittivi di risposta nel carcinoma ovarico | 1-gen-2000 | Scambia, G; Fagotti, A; Legge, F; Ferrandina, G; Fanfani, F; Mancuso, S | |
| Large-field pre-operative chemoradiation in locally advanced carcinoma of the cervix: preliminary results of a phase I study (LARA-CC-1) | 1-gen-2008 | Macchia, G; Morganti, Ag; Legge, F; Deodato, F; Digesù, C; Ferro, M; Caravatta, L; Ruggieri, V; Cocciolo, A; Travaglini, C; Piscopo, A; Ferrandina, G; Scambia, G; Valentini, V; Cellini, N | |
| Il carcinoma ovarico familiare | 1-gen-2000 | Greggi, S; Legge, F; Laurelli, G; Paparatti, M | |
| Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) in patients with advanced ovarian cancer (AOC): final analysis of the MITO-2 randomized multicenter trial | 1-gen-2010 | Pignata, S; Scambia, G; Savarese, A; Sorio, R; Breda, E; Legge, F; Gebbia, V; Musso, P; Gallo, C; Perrone, F on behalf of MITO group | |
| Phase II study on Pemetrexed in advanced and/or recurrent cervical cancer patients: a MITO study | 1-gen-2008 | Ferrandina, G; Lorusso, D; Ludovisi, M; Pignata, S; Sorio, R; Mangili, G; Breda, E; Legge, F; Pisconti, S; Scambia, G | |
| Intensified pre-operative chemoradiation in locally advanced carcinoma of the uterine cervix: final resultsof a phase I-II study (ESTER-1) | 1-gen-2008 | Macchia, G; Morganti, Ag; Legge, F; Deodato, F; Digesù, C; Ferro, M; Caravatta, L; Tambaro, R; Ferrandina, G; Sallustio, G; Smaniotto, D; Scambia, G; Valentini, V; Cellini, N | |
| Verso la classificazione molecolare dei tumori: possibili implicazioni prognostiche e terapeutiche | 1-gen-2003 | Legge, F; Ferrandina, G; Gallotta, V; Scambia, G | |
| COX-2 inhibition in gynaecological cancers | 1-gen-2005 | Legge, F; Ferrandina, G; Scambia, G. COX-2 inhibition in gynaecological cancers. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ...246
Data di pubblicazione
- 2020 - 202454
- 2010 - 2019118
- 2000 - 200957
- 1990 - 199916
- 1987 - 19891
Editore
- Accademia Italiana di Economia Az...2
- Elsevier2
- World Business Institute2
- B.S.LAB1
- Diamond Scientific Publishing1
- Edizioni MAF Servizi1
- OXFORD UNIV PRESS1
- Rogiosi Editore1
- Società Italiana di Farmacologia1
- Wiley-Blackwell1
Rivista
- ACTA PHYSIOLOGICA7
- BIOPHYSICAL JOURNAL7
- JOURNAL OF CLINICAL ONCOLOGY5
- THROMBOSIS RESEARCH5
- THROMBOSIS AND HAEMOSTASIS4
- INTERNATIONAL JOURNAL OF GYNECOLO...3
- SCHIZOPHRENIA BULLETIN3
- CANCER RESEARCH2
- FIBRINOLYSIS2
- PHARMACOLOGICAL RESEARCH2
Keyword
- AQP43
- oral health3
- TRPV43
- Dentistry2
- Engagement2
- Italy2
- juvenile2
- N.A2
- n.a2
- Paleolithic2
Lingua
- eng115
- ita13
Accesso al fulltext
- no fulltext246